Paget's disease of bone (PDB) affects 1-2 million Americans. The primary lesion in PDB is the formation of abnormal osteoclasts (OCL), which leads to highly localized bone resorption accompanied by exuberant new bone formation that is of poor quality. The OCL are increased in number and size, including increased nuclei/OCL, and express a "pagetic phenotype" that distinguishes them from normal OCL. Pagetic OCL precursors form OCL more quickly and at lower levels of inducers of OCL differentiation, including receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor ?, and 1,25-(OH)2D3. Another aspect of the pagetic OCL phenotype is the increased expression and secretion of the cytokine interleukin-6, which plays a large role in the development of pagetic OCL. Further, a number of key internal signaling molecules and transcription factors are altered in both pagetic OCL precursors and pagetic OCL. Lastly, pagetic OCL express increased coupling factors to promote osteoblastic differentiation. OCLs in PDB play a critical role in the enhanced osteoblast activity in PDB, since therapies targeting OCLs decrease new bone formation and induce clinical remission in PDB.
|Original language||English (US)|
|Title of host publication||Advances in Pathobiology and Management of Paget's Disease of Bone|
|Number of pages||17|
|State||Published - May 9 2016|
- Measles virus nucleocapsid protein
- Paget's disease
ASJC Scopus subject areas